Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology
|
November 12, 2005
[Sirolimus-eluting stent for in-stent restenosis treatment: single center results in an unselected study population]
Francesco Bellandi, Anna Toso, Mauro Maioli, et al.
The American Journal of Cardiology
|
June 14, 2002
Predicting revascularization outcome in patients with coronary artery disease and left ventricular dysfunction (data from the SEMINATOR study)
Roberto Sciagrà, Mario Leoncini, Giorgio Cannizzaro, et al.
Cardiorenal Medicine
|
May 21, 2020
A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study
Anna Toso, Mario Leoncini, Mauro Maioli, et al.
Journal of the American College of Cardiology
|
October 1, 2013
Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome)
Mario Leoncini, Anna Toso, Mauro Maioli, et al.
Circulation
|
May 18, 2012
Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis
Mauro Maioli, Anna Toso, Mario Leoncini, et al.
Clinical Cardiology
|
January 5, 2005
Markers of myocardial reperfusion as predictors of left ventricular function recovery in acute myocardial infarction treated with primary angioplasty
Francesco Bellandi, Mario Leoncini, Mauro Maioli, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
June 24, 2005
Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off-hours compared with direct primary intervention during regular hours
Mauro Maioli, Michela Gallopin, Mario Leoncini, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
November 4, 2010
Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction
Anna Toso, Mario Leoncini, Mauro Maioli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
February 19, 2010
Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention
Mauro Maioli, Anna Toso, Michela Gallopin, et al.
American Heart Journal
|
December 3, 2014
Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study
Mario Leoncini, Anna Toso, Mauro Maioli, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology
|
November 12, 2005
[Sirolimus-eluting stent for in-stent restenosis treatment: single center results in an unselected study population]
Francesco Bellandi, Anna Toso, Mauro Maioli, et al.
The American Journal of Cardiology
|
June 14, 2002
Predicting revascularization outcome in patients with coronary artery disease and left ventricular dysfunction (data from the SEMINATOR study)
Roberto Sciagrà, Mario Leoncini, Giorgio Cannizzaro, et al.
Cardiorenal Medicine
|
May 21, 2020
A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study
Anna Toso, Mario Leoncini, Mauro Maioli, et al.
Journal of the American College of Cardiology
|
October 1, 2013
Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome)
Mario Leoncini, Anna Toso, Mauro Maioli, et al.
Circulation
|
May 18, 2012
Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis
Mauro Maioli, Anna Toso, Mario Leoncini, et al.
Clinical Cardiology
|
January 5, 2005
Markers of myocardial reperfusion as predictors of left ventricular function recovery in acute myocardial infarction treated with primary angioplasty
Francesco Bellandi, Mario Leoncini, Mauro Maioli, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
June 24, 2005
Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off-hours compared with direct primary intervention during regular hours
Mauro Maioli, Michela Gallopin, Mario Leoncini, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
November 4, 2010
Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction
Anna Toso, Mario Leoncini, Mauro Maioli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
February 19, 2010
Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention
Mauro Maioli, Anna Toso, Michela Gallopin, et al.
American Heart Journal
|
December 3, 2014
Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study
Mario Leoncini, Anna Toso, Mauro Maioli, et al.
Page
of 5